Literature DB >> 624032

Cimetidine and serum prolactin.

S K Majumdar, A D Thomson, G K Shaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 624032      PMCID： PMC1602947          DOI： 10.1136/bmj.1.6110.409

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Gynaecomastia with cimetidine.

Authors:  G F Delle Fave; G Tamburrano; L De Magistris; C Natoli; M L Santoro; R Carratu; A Torsoli
Journal:  Lancet       Date:  1977-06-18       Impact factor: 79.321

2.  Galactorrhoea with cimetidine.

Authors:  M C Bateson; M C Browning; A Maconnachie
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

3.  Dopamine is an important neurotransmitter in the autonomic nervous system.

Authors:  M O Thorner
Journal:  Lancet       Date:  1975-03-22       Impact factor: 79.321
  3 in total
  9 in total

1.  Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).

Authors:  M Colle; E Ruedas; J Cazenave; J Auzerie; G Basilisco; G Camboni; L Manara
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Effect of cimetidine on gonadal function in man.

Authors:  C Wang; C L Lai; K C Lam; K K Yeung
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

4.  Stimulation of prolactin release by intravenous cimetidine: a dose-response study.

Authors:  R Caldara; L Bierti; C Barbieri; M Cambielli; M Romussi; C Ferrari
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

Review 5.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 6.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Gynaecomastia associated with cimetidine.

Authors:  R W Spence; L R Celestin
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

Review 8.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

9.  Endocrine effects of acute and chronic cimetidine administration.

Authors:  H E Carlson; A F Ippoliti; R S Swerdloff
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.